ArticleWorld journal of gastrointestinal endoscopy2025
Anal neoplasm in colonoscopy: What endoscopists need to know.
Article in World journal of gastrointestinal endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Clinical value of rectal retroflexion during colonoscopy: a retrospective analysis.BMC gastroenterology · 2026Article
- Detecting anal squamous dysplasia during routine colonoscopy.Proceedings (Baylor University. Medical Center)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe question of whether a colonoscopist should evaluate anal diseases is relevant. Endoscopists need to be aware of the possibility of anal neoplasms during a colonoscopy, as they can be easily overlooked if not properly examined. Specifically, one must clarify the responsibility of the colonoscopist in the diagnosis of anal neoplasms. Anal cancer is relatively rare, accounting for less than 2% of all cases annually. Owing to its rarity, population screening for anal cancer is not indicated, and monitoring is limited to high-risk groups. However, the number of anal cancer cases in high-risk groups has increased over the past four decades worldwide.
aimTo assess the results of anal examinations performed during routine colonoscopy and emphasize the importance of diagnosing anal neoplasms.
methodsThis was a retrospective study of 16836 patients who were screened by colonoscopy and received a detailed anal examination by videoanoscopy between 2006 and 2024. Among several other findings, the presence of anal neoplasms and suspicious anal cancer lesions was observed. All examinations, including complete anal examination, inspection, digital rectal examination, and videoanoscopy, were performed, and images were recorded and reported. The examinations were individually viewed by the work group, and the findings were analyzed.
resultsAmong the 22676 colonoscopies performed, 16836 patients were identified, and 88 lesions suspected of neoplasia (0.52%) were found. Among them, there were 23 cases of neoplasia (0.13%), 9 cases of confirmed squamous cell carcinoma of the anal canal (0.05%), 5 cases of adenocarcinoma in the anal canal (0.03%), 3 cases of rare neoplasms (0.01%), and 6 cases of adenoma (0.03%).
conclusionThe systematic performance of anal examinations and anoscopy during routine colonoscopy allows the identification of numerous anal diseases, including incidental cases of anal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.